Every time a doctor writes a prescription and a pharmacist dispenses a medicine, they are participating in a legal framework that has been carefully constructed to prevent harm. At the centre of that framework — for the vast majority of medicines routinely prescribed in Indian clinical practice — are Schedule H and Schedule H1 of the Drugs and Cosmetics Act, 1940. These schedules define which medicines may only be dispensed against a valid doctor's prescription, and they carry serious legal consequences for those who circumvent them.
For practising doctors, understanding these rules is not merely academic. Prescription irregularities are among the most common grounds for Medical Council complaints and pharmacy prosecutions in India. A doctor who issues improperly formatted prescriptions, or whose prescriptions are misused, can face disciplinary proceedings, criminal liability, and reputational damage.
"Most doctors know that certain drugs require a prescription — but very few have actually read what a legally compliant prescription must contain. The gap between clinical practice and legal requirement is where complaints arise."
— Dr. Namit Gupta, Senior Medico-Legal Expert
The Legal Basis: Drugs and Cosmetics Act 1940, Rule 65(15)
The Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, together form the primary statutory framework governing medicines in India. Rule 65(15) of the Drugs and Cosmetics Rules is the specific provision that creates Schedule H — it lists medicines that may not be sold by retail except against the prescription of a registered medical practitioner, and the prescription must be retained by the pharmacist.
The Schedule H list was originally introduced to control medicines that carry significant risks — those with narrow therapeutic windows, abuse potential, serious side effects, or that could mask symptoms of serious disease if self-administered. The principle behind the schedule is simple: these are drugs whose risks outweigh their benefits unless used under medical supervision.
What Is Schedule H1 — And Why Was It Introduced?
Schedule H1 was introduced in 2013 through an amendment to the Drugs and Cosmetics Rules, in response to growing alarm over antibiotic resistance and the rampant over-the-counter sale of powerful antibiotics. It created a stricter sub-category within the prescription-only regime.
The rationale was specific: certain antibiotics — particularly third-generation cephalosporins, fluoroquinolones, and carbapenems — were being sold freely across pharmacy counters without prescriptions, driving antimicrobial resistance at a population level. By placing them in Schedule H1, the government imposed additional recordkeeping requirements on pharmacies and required manufacturers to print a distinctive red "Rx" symbol on the outer label, making it clearly identifiable as a Schedule H1 medicine.
Schedule H1 also includes certain habit-forming drugs beyond antibiotics — including some antiretrovirals, second-line anti-tuberculosis drugs, and specific hormonal preparations — wherever their unsupervised use poses particular public health risks.
Key Drugs in Each Schedule
Common Schedule H Drugs
- Antihypertensives: Amlodipine, enalapril, losartan, metoprolol
- Antidiabetics: Metformin, glibenclamide, sitagliptin
- Psychiatric medications: Alprazolam, clonazepam (low-dose), escitalopram, sertraline
- First-line antibiotics: Amoxicillin, cotrimoxazole, doxycycline, metronidazole
- Cardiovascular drugs: Warfarin, digoxin, furosemide
- Anti-epileptics: Phenytoin, carbamazepine, valproate
- Corticosteroids: Prednisolone, betamethasone, hydrocortisone
- Hormones: Thyroxine, insulin, estrogen and progesterone preparations
Common Schedule H1 Drugs
- Third-generation cephalosporins: Cefixime, ceftriaxone, cefpodoxime, cefdinir
- Fluoroquinolones: Ciprofloxacin, levofloxacin, ofloxacin, moxifloxacin
- Carbapenems: Imipenem-cilastatin, meropenem, ertapenem
- Macrolides (certain): Azithromycin, clarithromycin
- Second-line anti-TB drugs: Ethionamide, cycloserine, capreomycin
- Antiretrovirals: Zidovudine, lamivudine, efavirenz (where not dispensed through government ART centres)
Schedule H vs Schedule H1: A Direct Comparison
| Feature | Schedule H | Schedule H1 |
|---|---|---|
| Label marking | "Rx" or "Schedule H" on pack | Red "Rx" symbol on outer label |
| Prescription required? | Yes — valid Rx from registered practitioner | Yes — stricter format with Rx retention |
| Pharmacy register | General prescription register | Separate H1 register with patient details, preserved 2 years |
| Primary drugs | Antihypertensives, antidiabetics, first-line antibiotics, psychiatric drugs | 3rd-gen cephalosporins, fluoroquinolones, carbapenems, 2nd-line anti-TB |
| Drug Inspector access | Can inspect prescription register | Must produce H1 register on demand |
What a Legally Compliant Prescription Must Contain
Under Rule 65(15) read with Rule 65(16) of the Drugs and Cosmetics Rules, a prescription for a Schedule H or H1 drug must contain all of the following:
- Date of writing
- Name and address of the prescribing doctor
- Registration number of the prescribing doctor (as issued by the State Medical Council / NMC)
- Name and address of the patient
- Age of the patient (particularly relevant for paediatric prescriptions)
- Name of the drug (generic/INN name is now mandatory under NMC 2023 regulations)
- Dose, dosage form, frequency, and duration of treatment
- Quantity to be dispensed
- Signature of the prescribing doctor
A prescription that lacks the doctor's registration number, or that is undated, or that does not specify the patient's name, is not legally compliant — even if it is signed by a registered doctor. Pharmacists are required by law to verify the completeness of the prescription before dispensing.
Obligations on Pharmacies and Pharmacists
A licensed pharmacy dispensing Schedule H or H1 drugs must:
- Dispense only against a valid prescription from a registered medical practitioner
- Retain the original prescription (for Schedule H drugs), or a copy (for Schedule H1, with cross-reference to the register)
- Maintain the general prescription register for Schedule H drugs
- Maintain a separate Schedule H1 register with entries for every Schedule H1 drug dispensed, including the patient's name, address, age, prescriber's name and registration number, drug name and quantity, and the dispensing date
- Preserve Schedule H1 registers for at least two years
- Make all records available to a Drug Inspector on demand
Pharmacists who dispense Schedule H or H1 drugs without a valid prescription face prosecution under Sections 27 and 28 of the Drugs and Cosmetics Act, which carry fines and imprisonment. Their pharmacy licence can also be suspended or cancelled by the State Drugs Controller.
Legal Consequences for Doctors
Medical Council Disciplinary Action
Under the NMC Act 2019 and its predecessors, a registered medical practitioner is expected to comply with all applicable law. A doctor who issues prescriptions in an improper format — or who issues blank pre-signed prescriptions, or who prescribes Schedule H drugs for non-therapeutic purposes — can be reported to the State Medical Council or the NMC's Ethics and Medical Registration Board (EMRB). Disciplinary consequences range from a formal warning to temporary suspension or permanent erasure from the medical register.
Criminal Prosecution Under the D&C Act
While criminal prosecution under the Drugs and Cosmetics Act is more commonly directed at manufacturers and pharmacists, doctors are not immune. A doctor who abets or facilitates unlawful dispensing — for example, by issuing forged or falsified prescriptions, or by running an arrangement with a pharmacy to dispense without actual prescriptions — can face prosecution under Section 27 (sale of drugs in contravention of the Act), which provides for imprisonment of up to three years and a fine.
Cases of Prosecution
Drug Controllers across Indian states periodically carry out enforcement drives targeting pharmacies that dispense Schedule H1 antibiotics without prescriptions. In several documented cases, drug inspectors in Maharashtra, Tamil Nadu, and Delhi have raided pharmacies, seized Schedule H1 drugs dispensed without prescriptions, and initiated prosecution against the pharmacy owner. In a number of these cases, the trail has led back to doctors issuing informal oral instructions to pharmacies rather than written prescriptions.
In 2019, the Maharashtra FDA conducted a state-wide audit of Schedule H1 compliance and found widespread violations — with many pharmacies maintaining no H1 register at all. Several pharmacy licences were cancelled. The FDA also served notices to doctors in some cases where prescriptions bore no registration numbers.
How to Protect Yourself as a Prescriber
The following practices will protect a prescribing doctor from legal exposure:
- Always include your MCI/NMC registration number on every prescription — this is non-negotiable
- Date every prescription and ensure patient details are complete
- Never issue blank or pre-signed prescriptions for pharmacies to fill in later
- Prescribe generic/INN names in capital letters as required by NMC 2023 Regulations
- Specify dose, frequency, duration, and quantity — do not leave fields incomplete
- Maintain a prescription copy or register in your clinic — this is your evidence if a prescription is later disputed
- For Schedule H1 drugs, ensure you have a documented clinical rationale for prescribing that specific drug over first-line alternatives
- Be particularly cautious about repeat prescriptions for Schedule H1 antibiotics — each prescription episode should be clinically justified
Conclusion
Schedule H and Schedule H1 are not bureaucratic formalities — they are the legal architecture that separates rational, supervised use of powerful medicines from the free-for-all that drives drug resistance and patient harm. For doctors, compliance is both a professional obligation and a matter of self-protection. A correctly written prescription — complete with registration number, patient details, generic drug name, dose, and duration — is the single most effective defence against a pharmacy complaint or Medical Council notice.
If you have received a notice related to prescription practices, or need guidance on compliant prescribing for your specialty, contact our medico-legal team for a confidential assessment.